Piper Sandler Reiterates Overweight Rating on Globus Medical (GMED)

June 9, 2026 8:44 AM

Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $115.00 price target on Globus Medical (NYSE: GMED).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found